Adaptive Biotechnologies Corporation
ADPT
Jodie situation report
Adaptive Biotechnologies Corporation's current read is isolated; its market group is not confirming.
The latest filing is mixed. 0 of 9 group members are active now; 0 filing-linked outsiders are moving with the group, and 0 of 1 directly disclosed connection is confirming.
- Revenue increased 21.5% versus the comparable filing period.
- Operating cash flow remained negative at -15.9M.
- ADPT's market-adjusted activity becomes unusual and at least one connected name confirms.
Invalidation: The isolated read changes if ADPT's group or a disclosed connection begins moving with it.
Who this business touches
The relationships behind ADPT
Customers, suppliers, partners and competitors named in company filings—not inferred from headlines.
Depended on by
CAICaris Life Sciences, Inc.competitorMar 3, 2026 ▾
“Our competitors in blood-based molecular profiling for MRD tracking and treatment monitoring include Natera, Guardant Health, SAGA Diagnostics, Personalis, BillionToOne, Quest Diagnostics and Adaptive Biotechnologies.”
Filing peers
Companies whose filings use similar operating language.
Open the three relationships above to see Jodie’s filing proof. Pro unlocks 1 more links, every receipt, and alerts when connected names begin moving. Unlock the full network →
What is moving around it
Live connections
ADPT is currently a Follower in the organic co-movement group Speculative Growth. This group is discovered from market behaviour rather than assigned from an industry taxonomy. 1 filing-linked name are in the relationship map; none is currently confirmed as moving with the group.